Enhancement of T cell-independent immune responses in vivo by CD40 antibodies

Nature Medicine

Volumn 4, Issue 1, 1998, Pages 88-91

  Dullforce, Per ^a   Sutton, Debbie C ^a   Heath, Andrew W ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; HAEMOPHILUS VACCINE; PNEUMOCOCCUS VACCINE;

ACTIVE IMMUNIZATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIGEN RECOGNITION; ARTICLE; HAEMOPHILUS INFLUENZAE; IMMUNOGENICITY; IMMUNOREGULATION; IMMUNOSTIMULATION; INFECTION PREVENTION; MOUSE; NEISSERIA GONORRHOEAE; NONHUMAN; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD40; B-LYMPHOCYTES; BACTERIAL VACCINES; CD4-POSITIVE T-LYMPHOCYTES; HUMANS; INFANT; LYMPHOCYTE DEPLETION; MICE; MICE, INBRED BALB C; MICE, INBRED CBA; PNEUMOCOCCAL VACCINES; POLYSACCHARIDES, BACTERIAL; STREPTOCOCCUS PNEUMONIAE; T-LYMPHOCYTES;

EID: 0031938031     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0198-088     Document Type: Article

References (29)

1. Robbins, J.B., Schneerson, R. & Szu, S.C. Hypothesis: Serum IgG antibody is sufficient to confer protection against infectious diseases by inactivating the inoculum. I. Infect. Dis. 171, 1387-1398 (1995).
2. Landesman, S.H. & Schiffman, G. Assessment of the antibody response to pneumococcal vaccine in high risk populations. Rev. Infect. Dis. 3, S184-S197 (1981).
3. Alonso De Velasco, E., Verheul, A.F.M., Verhoef, J. & Snippe, H. Streptococcus pneumoniae : Virulence factors, pathogenesis and vaccines. Microbiol. Rev. 59, 591-603 (1995).
4. Mond, J.J., Lees, A. & Snapper, C.M. T-cell-independent antigens type-2. Annu. Rev. Immunol. 13, 655-692 (1995).
5. Armitage, R.J. et al. Molecular and biological characterization of a murine ligandfor CD40. Nature 357, 80-82 (1992).
6. Renshaw, B.R. et al. Humoral immune responses in CD40 ligand-deficient mice. J. Exp. Med. 180, 1889-1900 (1994).
7. Castigli, E. et al. CD40-deficient mice generated by recombination-activating gene-2-deficient blastocyst complementation. Proc Natl. Acad. Sci. USA 91, 12135-12139 (1994).
8. Kawabe, T et al. The immune-response In CD40-deficient mice - impaired immunoglobulin class switching and germinal center formation. Immunity 1, 167-178 (1994).
9. Xu, J. et al. Mice deficient for the CD40 ligand. Immunity 1, 423-431 (1994).
10. Heath, A.W., Wu, W.W. & Howard, M.C Monoclonal antibodies to murine CD40 define two distinct functional epitopes. Eur. J. Immunol. 24, 1828-1834 (1994).
11. Coffman, R.L, Lebman, D.A. & Rothman, P. Mechanism and regulation of immunoglobulin isotype switching. Adv. Immunol. 54, 229-270 (1993).
12. Warren, W.D. & Berton, M.T. Induction of germ-line gamma-1 and epsilon Ig gene expression in murine B cells: IL-4 and the CD40 ligand-CD40 interaction provide distinct but synergistic signals. J. Immunol. 155, 5637-5646 (1995).
13. Kuhn, R., Rajewsky, K, & Muller, W. Generation and analysis of interleukin-4 deficient mice. Science 254, 707-710 (1991).
14. Schultz, C.L. et al. T helper cell membranes promote IL-4-independent expression of germ-line C-gamma-1 transcripts in B cells, J. Immunol. 149, 60-64 (1992).
15. Ferlin, W.G. et al. CD40 signaling induces interleukin-4-independent IgE switching in vivo, Eur. J. Immunol. 26, 2911-2915 (1996).
16. Armitage, R.J. et al. CD40 ligand is a T cell growth factor. Eur. J. Immunol. 23, 2326-2331 (1993).
17. Kennedy, M.K. et al. Induction of B cell costimulatory function by recombinant murine CD40 ligand. Eur. J. Immunol. 24, 116-123 (1994).
18. Yang, Y.P. & Wilson, J.M CD40 ligand-dependent T cell activation; Requirement of B7-CD28 signaling through CD40. Science 273, 1862-1864 (1996).
19. Fanslow, W.C. et al. Recombinant CD40 ligand exerts potent biologic effects on T cells. J. Immunol. 152, 4262-4269 (1994).
20. Ahmed, F. et al. Effect of human immunodeficiency virus type 1 infection on the antibody response to a glycoprotein conjugate pneumococcal vaccine: Results from a randomised trial. J. Infect. Dis. 173, 83-90 (1996).
21. Carson, P.J., Schut, R.L., Simpson, M.L., O'Brien, J. & Janoff, E.N. Antibody and subclass responses to pneumococcal polysaccharides following immunization of human immunodeficiency virus-infected patients. J. Infect. Dis. 172, 340-345 (1995).
22. Rijkers, G.T., Sanders, E.A.M., Breukels, M.A. & Zegers, B.J.M. Responsiveness of infants to capsular polysaccharides: Implications for vaccine development. Rev. Med. Microbiol. 7, 3-12 (1996).
23. Lee, H.-J. et al. Immunogenicity and safety of a 23-valent pneumococcal polysaccharide vaccine in healthy children and in children at increased risk of pneumococcal infection. Vaccine 13, 1533-1538 (1995).
24. Käyhty, H., Karanko, V., Peltola, H. & Mäkelä, P.H. Serum antibodies after vaccination with Haemophilus influenzae type b capsular polysaccharide and responses to immunization: No evidence of immunologic tolerance or memory. Pediatrics 74, 857-865 (1984).
25. Douglas, R.M., Paton, J.C., Duncan, S.J. & Hansman, D.J. Antibody response to pneumococcal vaccination in children younger than five years of age. J. Infect. Dis. 148, 131-137 (1983).
26. Scher, I. CBA/N immune defective mice: Evidence for the failure of a B cell subpopulation to be expressed. Immunol. Rev. 64, 117-136 (1982).
27. Hasbold, J. & Klaus, G.G.B. B Cells From CBA/N mice do not proliferate following ligation of CD40. fur. J. Immunol. 24, 152-157 (1994).
28. Santos-Argumedo, L. et al. CD38 unresponsiveness of xid B cells implicates Bruton's tyrosine kinase (btk) as a regulator of CD38 induced signal transduction. Int. Immunol. 7, 163-170 (1995).
29. Konradsen, H.B., Sørensen, U.B.S. & Henrichsen, J. A modified enzyme-linked immunosorbent assay for measuring type-specific anti-pneumococcal capsular polysaccharide antibodies. J. Immunol. Methods 164, 13-20 (1993).